Clinical Trial Update: Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon [Phase 3]

View source ↗

Summary

Phase 3 trial investigating combined SSRI and ramelteon for time to remission of depressive symptoms in major depressive disorder with insomnia; study terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Major Depressive Disorder

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Major Depressive Disorder, Insomnia | Phase 3 | Status: TERMINATED | Results posted: 2012-10-26